BridgeBio Pharma, Inc. (BBIO)
68.09
-0.69
(-1.00%)
USD |
NASDAQ |
May 06, 16:00
68.11
+0.02
(+0.03%)
Pre-Market: 08:26
BridgeBio Pharma Free Cash Flow : -455.50M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 9.484B |
| Mirum Pharmaceuticals, Inc. | 54.87M |
| Insmed, Inc. | -997.58M |
| Eli Lilly & Co. | 10.37B |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -56.42M |
| Cash from Investing (Quarterly) | -13.75M |
| Cash from Financing (Quarterly) | -2.782M |
| Free Cash Flow Per Share (Quarterly) | -0.2917 |
| Free Cash Flow to Equity (Quarterly) | -80.71M |
| Free Cash Flow to Firm (Quarterly) | -6.17M |
| Free Cash Flow Yield | -3.49% |